Paul Mieyal
Verified
Senior investment professional with over 17 years of experience investing in growth-stage companies in medical devices, biotechnology, and diagnostics. Public company executive operational experience, including capital raising, FDA product approval, strategic licensing, and investor relations. Extensive due diligence experience as investment lead and syndicated investor. Public and private board representative with experience in M&A, IPOs, restructuring, and management transitions.